Zoetis Says EC Grants Marketing Authorization for Antiparasitic Medication for Dogs
September 20 2019 - 10:09AM
Dow Jones News
By Michael Dabaie
Zoetis Inc. (ZTS) said the European Commission granted marketing
authorization for Simparica Trio chewable tablets, a once-monthly
triple combination antiparasitic medication for dogs.
The marketing authorization follows a positive opinion adopted
by the Committee for Medicinal Products for Veterinary Use in
July.
Zoetis said it expects to launch Simparica Trio in the EU in the
first quarter of 2020.
Shares were up about 1% in early trading.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
September 20, 2019 09:54 ET (13:54 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024